HomeCompareFLCEX vs MRK

FLCEX vs MRK: Dividend Comparison 2026

FLCEX yields 9.54% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FLCEX wins by $6.8K in total portfolio value
10 years
FLCEX
FLCEX
● Live price
9.54%
Share price
$20.97
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.6K
Annual income
$1,738.36
Full FLCEX calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — FLCEX vs MRK

📍 FLCEX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFLCEXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FLCEX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FLCEX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FLCEX
Annual income on $10K today (after 15% tax)
$810.68/yr
After 10yr DRIP, annual income (after tax)
$1,477.61/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, FLCEX beats the other by $669.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FLCEX + MRK for your $10,000?

FLCEX: 50%MRK: 50%
100% MRK50/50100% FLCEX
Portfolio after 10yr
$34.2K
Annual income
$1,344.33/yr
Blended yield
3.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FLCEX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FLCEX buys
0
MRK buys
0
No recent congressional trades found for FLCEX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFLCEXMRK
Forward yield9.54%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$37.6K$30.7K
Annual income after 10y$1,738.36$950.29
Total dividends collected$13.5K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FLCEX vs MRK ($10,000, DRIP)

YearFLCEX PortfolioFLCEX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,654$953.74$11,192$351.54+$462.00FLCEX
2$13,508$1,038.76$12,524$392.70+$984.00FLCEX
3$15,579$1,125.29$14,015$438.65+$1.6KFLCEX
4$17,883$1,212.90$15,682$489.96+$2.2KFLCEX
5$20,435$1,301.15$17,547$547.23+$2.9KFLCEX
6$23,256$1,389.63$19,632$611.16+$3.6KFLCEX
7$26,361$1,477.94$21,963$682.53+$4.4KFLCEX
8$29,772$1,565.72$24,571$762.18+$5.2KFLCEX
9$33,509$1,652.63$27,486$851.08+$6.0KFLCEX
10$37,593$1,738.36$30,745$950.29+$6.8KFLCEX

FLCEX vs MRK: Complete Analysis 2026

FLCEXStock

The investment seeks capital appreciation. The fund normally invests at least 80% of assets in common stocks included in the S&P 500® Index, which is a market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance. It invests in domestic and foreign issuers.

Full FLCEX Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this FLCEX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FLCEX vs SCHDFLCEX vs JEPIFLCEX vs OFLCEX vs KOFLCEX vs MAINFLCEX vs JNJFLCEX vs ABBVFLCEX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.